株式会社D&Mカンパニー Logo

株式会社D&Mカンパニー

Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.

189A | T

Overview

Corporate Details

ISIN(s):
JP3548490006
LEI:
Country:
Japan
Address:
大阪市北区梅田二丁目5番25号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D&M COMPANY CO.,LTD is a specialized provider of comprehensive business support services for the medical, nursing care, and welfare industries. The company offers integrated, one-stop solutions structured around three core pillars: Finance & Investment (F&I), Consulting & Business Renovation (C&Br), and Human Resources & Outsourcing (HR&OS). The F&I division provides financial solutions such as medical fee receivables factoring and leasing. The C&Br division offers management consulting, including organizational reform, profit improvement support, and M&A advisory. The HR&OS division delivers staffing services like personnel placement, temporary staffing, and outsourcing. By holistically addressing key client challenges in finance, management, and human resources, D&M aims to achieve overall business optimization for healthcare and welfare service providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 330.4 KB
2025-08-25 06:04
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.3 MB
2025-08-25 06:04
Registration Form
確認書
Japanese 9.2 KB
2025-01-14 05:43
Report Publication Announcement
確認書
Japanese 9.3 KB
2025-01-14 05:41
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 179.0 KB
2024-08-27 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-08-26 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-08-26 08:00
Annual Report
有価証券報告書-第9期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-06-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-24 02:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-08 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all 株式会社D&Mカンパニー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社D&Mカンパニー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社D&Mカンパニー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KOGI CORPORATION Logo
Engineering AI & IoT zero-touch hover interfaces for public kiosks and terminals.
Japan
5603
KOLON CORPORATION Logo
A holding company for diverse businesses in materials, chemicals, fashion, and life sciences.
South Korea
002020
kt nasmedia Co., Ltd. Logo
An integrated digital marketing platform for data-driven online, mobile, and OOH ad solutions.
South Korea
089600
Kubota Pharmaceutical Holdings Co., Ltd. Logo
Developing ophthalmic drugs and devices to preserve and restore vision for patients globally.
Japan
4596
Kweather Co., Ltd. Logo
Provider of weather data, air quality monitoring, and enterprise climate management solutions.
South Korea
068100
Kymera Therapeutics, Inc. Logo
Fintech firm providing data analytics and market intelligence for investment professionals.
United States of America
KYMR
LABCORP HOLDINGS INC. Logo
Provides diagnostic lab testing and biopharma drug development services for healthcare clients.
United States of America
LH
LAMAR ADVERTISING CO/NEW Logo
A leading OOH advertising REIT with billboards, transit, and airport displays in the US & Canada.
United States of America
LAMR
Larimar Therapeutics, Inc. Logo
Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.
United States of America
LRMR
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.
United States of America
LPTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.